Anti MAG Neuropathy
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| First in Human Study to Test the Safety and Preliminary Efficacy of PPSGG in Patients With Anti-MAG Neuropathy (NCT04568174) | Polyneuron Pharmaceuticals AG | 2020-11-17 |
| SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study (NCT02967679) | MedDay Pharmaceuticals SA | 2016-12-05 |
Track Anti MAG Neuropathy automatically
Every clearance here is in the API, with alerts when new ones post.